TMCnet News
INSYS Therapeutics Hires First Corporate Communications Leader and New Investor Relations AgencyPHOENIX, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("INSYS" or "the Company"), today announced the hiring of Joe McGrath as the Company’s Senior Director of Corporate Communications, and the retention of the Alpha IR Group (“Alpha IR”) as its investor relations agency of record. McGrath joins INSYS Therapeutics after nearly 16 years in public relations and corporate communications at Medtronic, where he served in a succession of functional roles for the neurological and cardiovascular divisions. In his new role at INSYS, McGrath is responsible for directing and conducting internal and external communications for the Company, including media relations, reputation management, and corporate brand development. McGrath will also support investor relations in collaboration with INSYS’s Chief Financial Officer, Andrew Long, and President and Chief Executive Officer, Saeed Motahari. Alpha IR is a boutique full-service investor relations consulting firm, whose leadership team brings over 100 years of combined Wall Street experience. Alpha IR’s healthcare specialists will support the enhancement of the Company’s engagement strategy with the investment community as well as provide ongoing strategic messaging and communications support to both internal and external stakeholders. “Joe is a great addition to the INSYS team, and I am confident that his deep experience and understanding of the healthcare sector will complement our new leadership team. His immediate focus will be on helping INSYS to establish, develop and maintain strong and principled relationships with our key stakeholders,” Moahari said. “Additionally, our partnership with Alpha IR is also an important milestone for the Company, as we seek to enhance our investor relations effort. We greatly appreciate the support we received from In-Site Communications throughout our transition from a privately held company to a publicly traded company.” About INSYS SUBSYS® and SYNDROS® are trademarks of Insys Development Company, Inc., a subsidiary of Insys Therapeutics, Inc. NOTE: All trademarks and registered trademarks are the property of their respective owners. About Alpha IR Group CONTACT: Media Relations Investor Relations |